Suppr超能文献

近期雌激素相关受体小分子调节剂设计的进展。

Recent advance in the design of small molecular modulators of estrogen-related receptors.

机构信息

Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, China.

出版信息

Curr Pharm Des. 2012;18(23):3421-31. doi: 10.2174/138161212801227113.

Abstract

The estrogen-related receptors (ERRs), comprising ERRα, ERRβ and ERRγ, are the members of the nuclear receptor superfamily, which have been functionally implicated in estrogen signal pathway in various patterns. However, no natural ligand of ERRs has been identified to data, so identification of the synthetic modulators (inverse agonist and agonist) of ERRs would be highly effective in the treatment of estrogen-related pathologies, such as diabetes, breast cancer and osteoporosis. This review summarizes the structures and biological functions of ERR subtypes, and the progress in designing the small molecular modulators of ERRs as well as the detailed description of available co-crystal structures of the LBD of ERRs in three distinct states: unligand, inverse agonist bound, and agonist bound.

摘要

雌激素相关受体(ERRs)包括 ERRα、ERRβ 和 ERRγ,是核受体超家族的成员,其在不同模式下参与雌激素信号通路。然而,到目前为止,还没有发现 ERRs 的天然配体,因此,鉴定 ERRs 的合成调节剂(反向激动剂和激动剂)对于治疗与雌激素相关的疾病(如糖尿病、乳腺癌和骨质疏松症)将非常有效。本文综述了 ERR 亚型的结构和生物学功能,以及设计 ERR 小分子调节剂的进展,并详细描述了 ERRs 的 LBD 在三种不同状态下(无配体、反向激动剂结合和激动剂结合)的现有共晶结构。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验